Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Some skin diseases and their treatments can negatively affect male fertility.

The document emphasizes the importance of correctly identifying and classifying genetic hair disorders to help diagnose related health conditions.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Testosterone can both promote hair growth and cause baldness by affecting hair growth signals.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Acne can be managed with various treatments and requires psychological support due to its emotional impact.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Healthy aging can be promoted through physical activity, lifestyle changes, and certain treatments.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

Pharmacists play a crucial role in improving treatment outcomes and staying updated on various health conditions.

The document concludes that understanding hair follicles requires more research using computational methods and an integrative approach, considering the current limitations in hair treatment products.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Spironolactone most effective for hirsutism, but has side effects.

Equisetum debile extract, especially the ethyl acetate type, may be a promising natural ingredient for anti-hair loss products.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

Reduced androgens linked to kinky hair disorder and hair loss; 5a-reductase inhibitors may help.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

Genetics can help tailor treatments for male pattern hair loss, improving outcomes like stabilization or modest regrowth.

Some alternative treatments for hair loss might work, but more research is needed.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.